Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTP348 in Solid Tumors and HNSCC
NCT02216669Phase 1Withdrawn
- Sponsor
- Maastro Clinic
- Start
- Mar 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of DTP-348 in solid tumor and head and neck squamous cell carcinoma (HNSCC), sponsored by Maastro Clinic. Planned start Mar 2017; status: withdrawn.
02
Drugs
DTP-348
03
Conditions
solid tumorhead and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02216669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02216669.